Coagulation Factor Ix Recombinant Human: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Coagulation Factor Ix Recombinant Human. Educational only — not medical advice.
Labeled uses
REBINYN, Coagulation Factor IX (Recombinant), GlycoPEGylated, is a recombinant DNA-derived coagulation Factor IX concentrate indicated for use in adults and children with hemophilia B (congenital Factor IX deficiency) for: • On-demand treatment and control of bleeding episodes • Perioperative management of bleeding • Routine prophylaxis to reduce the frequency of bleeding episodes Limitations of Use : REBINYN is not indicated for immune tolerance induction in patients with hemophilia B.
Source: FDA labeling via NIH DailyMed (set 0ea37235…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.